title: Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid.
abstract: OBJECTIVE
  The ability of hyaluronic acid (HA) to act as a functional additive in model silicone hydrogel contact lenses to alter the uptake and release characteristics of timolol was investigated.
  
  
  METHODS
  Model contact lenses were prepared using 2 primary formulations: 2-hydroxyethyl methacrylate (HEMA) with 3-methacryloxypropyltris (trimethylsiloxy) silane (TRIS) in a 9:1 (wt:wt) ratio or N,N-dimethylacrylamide (DMA) with TRIS in a 1:1 (wt:wt) ratio. Ethylene glycol dimethacrylate (EGDMA) was used as the cross-linker. Four different model lens compositions were explored: unmodified controls, lenses containing HA, lenses that were molecularly imprinted with timolol maleate, and those that were both imprinted and contained HA. Model lenses were then used in subsequent materials characterization, drug loading, and drug release studies.
  
  
  RESULTS
  Hyaluronic acid was shown to have the ability to act as a functional additive in these model contact lenses, significantly increasing the drug loading and release mass. This ability seemed to be independent of molecular imprinting, but its efficacy was related to the concentration of HA contained within model lenses and the concentration of drug loading solution used to facilitate uptake. Timolol release was sustained for a duration of approximately 2 days, and the dose of drug was shown to be controlled by both HA-drug interactions and molecular imprinting within the silicone hydrogels.
  
  
  CONCLUSIONS
  Hyaluronic acid, although different than typical functional monomers used in molecular imprinting, can be a useful additive to modify the mass of drug release from model silicone hydrogel lenses.
authors.affiliation: Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Giuliano
authors.initials: G
authors.lastname: Guidi
authors.forename: Myrto
authors.initials: M
authors.lastname: Korogiannaki
authors.forename: Heather
authors.initials: H
authors.lastname: Sheardown
mesh_terms: D000704:Analysis of Variance; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D003263:Contact Lenses, Hydrophilic; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems / Q000379:methods*; D006820:Hyaluronic Acid / Q000493:pharmacokinetics*; D020100:Hydrogels / Q000737:chemistry*; D012828:Silicones / Q000737:chemistry*; D013999:Timolol / Q000493:pharmacokinetics*
chemical_list: D000959:Antihypertensive Agents; D003692:Delayed-Action Preparations; D020100:Hydrogels; D012828:Silicones; D013999:Timolol; D006820:Hyaluronic Acid